Free Trial
Thank you for registering! Take a moment to confirm your subscription to MarketBeat Daily Ratings so that you can access MarketBeat's tools, reports, and news. Please click the "Send Confirmation Email" button and we'll send you an email with confirmation instructions.
Send Confirmation Email

Alaunos Therapeutics (TCRT) News Today

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)
Free TCRT Stock Alerts
$1.16
-0.06 (-4.92%)
(As of 05/17/2024 08:54 PM ET)
Compare
Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media
May 16, 2024 | investorplace.com
TCRT Stock Earnings: Alaunos Therapeutics Reported Results for Q1 2024
April 12, 2024 | seekingalpha.com
Revolution Medicines: An Expensive Shot At A Massive Market Opportunity
April 8, 2024 | investorplace.com
TCRT Stock Earnings: Alaunos Therapeutics Misses EPS for Q4 2023
April 1, 2024 | msn.com
Biora Therapeutics announces $6M registered direct offering and concurrent private placement
February 2, 2024 | marketbeat.com
Alaunos Therapeutics (NASDAQ:TCRT) Trading 9% Higher
Alaunos Therapeutics (NASDAQ:TCRT) Stock Price Up 9%
February 1, 2024 | marketbeat.com
Trading was temporarily halted for "TCRT" at 07:01 PM with a stated reason of "News pending."
January 31, 2024 | msn.com
Alaunos Therapeutics Announces 1-for-15 Reverse Stock Split
January 31, 2024 | investing.com
Werewolf Therapeutics Inc (HOWL)
December 28, 2023 | benzinga.com
Alaunos Therapeutics Stock (NASDAQ:TCRT) Dividends: History, Yield and Dates
November 14, 2023 | benzinga.com
Recap: Alaunos Therapeutics Q3 Earnings
November 14, 2023 | investorplace.com
Why Is Alaunos Therapeutics (TCRT) Stock Up 14% Today?
November 14, 2023 | finance.yahoo.com
Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued Exploration of Strategic Alternatives
November 1, 2023 | morningstar.com
Alaunos Therapeutics Inc TCRT
August 15, 2023 | msn.com
Why Is Alaunos Therapeutics Sinking Today?
August 14, 2023 | finance.yahoo.com
Alaunos Therapeutics Announces Second Quarter 2023 Financial Results, Interim Clinical Data and Exploration of Strategic Alternatives
August 14, 2023 | marketbeat.com
Trading was temporarily halted for "TCRT" at 04:08 PM with a stated reason of "News pending."
June 29, 2023 | finance.yahoo.com
Alaunos Therapeutics Announces Presentation at the 2nd Hawaii Global Summit on Thoracic Malignancies
June 9, 2023 | benzinga.com
Alaunos Therapeutics Stock (NASDAQ:TCRT), Insider Trading Activity
May 26, 2023 | msn.com
Alaunos slips 17% on Phase 1/2 data for cancer cell therapy
May 25, 2023 | finance.yahoo.com
Alaunos Therapeutics to Present Early Data from TCR-T Library Phase 1/2 Trial at 2023 American Society of Clinical Oncology Annual Meeting
May 17, 2023 | uk.news.yahoo.com
One Alaunos Therapeutics Insider Raised Stake By 117% In Previous Year
May 15, 2023 | seekingalpha.com
Alaunos Therapeutics upgraded to buy at Wainwright on multiple catalysts
May 13, 2023 | finance.yahoo.com
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Q1 2023 Earnings Call Transcript
May 11, 2023 | marketwatch.com
8-K: Alaunos Therapeutics, Inc.
May 10, 2023 | finanznachrichten.de
Alaunos Therapeutics, Inc.: Alaunos Therapeutics Reports First Quarter 2023 Financial Results
May 10, 2023 | msn.com
Alaunos Therapeutics GAAP EPS of -$0.04 in-line
May 10, 2023 | msn.com
Recap: Alaunos Therapeutics Q1 Earnings
May 10, 2023 | finance.yahoo.com
Alaunos Therapeutics Reports First Quarter 2023 Financial Results
May 3, 2023 | finance.yahoo.com
Alaunos Therapeutics to Report First Quarter 2023 Financial Results on May 10, 2023
April 26, 2023 | finance.yahoo.com
Alaunos Therapeutics Announces Poster Presentation at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting
April 25, 2023 | finance.yahoo.com
The past five years for Alaunos Therapeutics (NASDAQ:TCRT) investors has not been profitable
April 2, 2023 | barrons.com
Alaunos Therapeutics Inc.
March 30, 2023 | finance.yahoo.com
Alaunos Therapeutics Appoints Dr. Robert J. Hofmeister to Board of Directors
March 29, 2023 | finance.yahoo.com
Alaunos Therapeutics to Participate in Upcoming Investor Conferences in April
March 13, 2023 | marketbeat.com
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) to Post FY2023 Earnings of ($0.17) Per Share, Cantor Fitzgerald Forecasts
Alaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) - Analysts at Cantor Fitzgerald dropped their FY2023 earnings estimates for Alaunos Therapeutics in a report released on Wednesday, March 8th. Cantor Fitzgerald analyst P. Agrawal now anticipates that the company will earn ($0.17) per share fo
March 10, 2023 | finance.yahoo.com
When Will Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Turn A Profit?
March 10, 2023 | marketbeat.com
Q1 2023 EPS Estimates for Alaunos Therapeutics, Inc. Increased by HC Wainwright (NASDAQ:TCRT)
Alaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) - Equities research analysts at HC Wainwright boosted their Q1 2023 EPS estimates for Alaunos Therapeutics in a research report issued to clients and investors on Wednesday, March 8th. HC Wainwright analyst S. Ramakanth now forecasts that the
March 9, 2023 | msn.com
Alaunos Therapeutics's Return On Capital Employed Overview
March 9, 2023 | finance.yahoo.com
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Q4 2022 Earnings Call Transcript
March 6, 2023 | msn.com
Earnings Outlook For Alaunos Therapeutics
March 3, 2023 | msn.com
Alaunos (TCRT) to Report Q4 Earnings: What's in the Cards?
March 1, 2023 | finance.yahoo.com
Alaunos Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results on March 7, 2023
February 28, 2023 | marketbeat.com
Ergoteles LLC Has $835,000 Holdings in Alaunos Therapeutics, Inc. (NASDAQ:TCRT)
Ergoteles LLC trimmed its position in Alaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) by 48.2% in the third quarter, according to its most recent filing with the SEC. The fund owned 485,434 shares of the company's stock after selling 451,466 shares during the period. Ergoteles LLC owned 0.22%
February 17, 2023 | finance.yahoo.com
Alaunos Therapeutics, Inc.'s (NASDAQ:TCRT) largest shareholders are individual investors with 58% ownership, institutions own 22%
January 24, 2023 | finance.yahoo.com
Is Alaunos Therapeutics (TCRT) Outperforming Other Medical Stocks This Year?
January 13, 2023 | marketbeat.com
FY2022 EPS Estimates for Alaunos Therapeutics, Inc. Lifted by Analyst (NASDAQ:TCRT)
Alaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) - Research analysts at Cantor Fitzgerald lifted their FY2022 earnings estimates for shares of Alaunos Therapeutics in a note issued to investors on Tuesday, January 10th. Cantor Fitzgerald analyst P. Agrawal now forecasts that the company will
January 9, 2023 | finance.yahoo.com
Alaunos Therapeutics Highlights Strategic Priorities and Anticipated Portfolio Milestones for 2023
December 29, 2022 | finance.yahoo.com
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Q3 2022 Earnings Call Transcript
December 4, 2022 | uk.news.yahoo.com
Trade Alert: The Independent Director Of Alaunos Therapeutics, Inc. (NASDAQ:TCRT), Jaime Vieser, Has Just Spent US$813k Buying 117% More Shares
December 1, 2022 | marketbeat.com
Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Director Robert W. Postma Buys 750,000 Shares
Alaunos Therapeutics, Inc. (NASDAQ:TCRT - Get Rating) Director Robert W. Postma bought 750,000 shares of Alaunos Therapeutics stock in a transaction dated Tuesday, November 29th. The stock was acquired at an average price of $0.65 per share, with a total value of $487,500.00. Following the purchase, the director now directly owns 5,000,000 shares of the company's stock, valued at $3,250,000. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Get Alaunos Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCRT and its competitors with MarketBeat's FREE daily newsletter.

Urgent Nvidia Warning (Ad)

Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.

Click here to access…

TCRT Media Mentions By Week

TCRT Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

TCRT
News Sentiment
▼
0.69

0.42
▲
Average
Medical
News Sentiment

TCRT News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

TCRT Articles
This Week
▼
2

0
▲
TCRT Articles
Average Week

Get Alaunos Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for TCRT and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:TCRT) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners
Shocking: One AI startup's revenue could surge 4,735%
Manward Press
The Overlooked Retirement Asset You Probably Don’t Own
Crypto 101 Media
Next President (Not Trump. Not Biden.)
The Freeport Society
Urgent Nvidia Warning
Altimetry
Elon’s New Device is About to Shock the World
InvestorPlace
"The Biggest Drug Ever" Is Coming
Behind the Markets
CEO of Biggest AI Chipmaker Just Dropped a Bombshell…
Banyan Hill Publishing
Exposed: 10 CENT Crypto to Explode May 20th?
True Market Insiders